Your browser doesn't support javascript.
loading
A commentary review on endoscopic sleeve gastroplasty: Indications, outcomes and future implications.
Abuawwad, Mahmoud; Tibude, Ameya; Bansi, Devinder; Idris, Iskandar; Madhok, Brijesh.
Afiliação
  • Abuawwad M; East Midlands Bariatric and Metabolic Institute (EMBMI), Royal Derby Hospital, Derby, UK.
  • Tibude A; Bariatric Surgery - General Surgery Department, Royal Sunderland Hospital, Sunderland, UK.
  • Bansi D; East Midlands Bariatric and Metabolic Institute (EMBMI), Royal Derby Hospital, Derby, UK.
  • Idris I; Honorary Clinical Senior Lecturer, Faculty of Medicine, Imperial College London, London, UK.
  • Madhok B; East Midlands Bariatric and Metabolic Institute (EMBMI), Royal Derby Hospital, Derby, UK.
Diabetes Obes Metab ; 26(7): 2546-2553, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38685614
ABSTRACT
Metabolic and bariatric surgeries have been shown to be the most effective strategy to induce and maintain significant weight loss for people living with severe obesity. However, ongoing concerns regarding operative risks, irreversibility and excess costs limit their broader clinical use. Endoscopic bariatric therapies are pragmatic alternatives for patients who are not suitable for metabolic and bariatric surgeries or who are concerned regarding their long-term safety. Endoscopic sleeve gastroplasty has emerged as a novel technique of endoscopic bariatric therapies, which have garnered significant interest and evidence in the past few years. Its safety, efficacy and cost-effectiveness have been shown in various studies, while comparisons with sleeve gastrectomy have been widely made. This review brings together current evidence pertaining to the technicality of the procedure itself, current indications, safety and efficacy, cost-effectiveness, as well as its future role and development.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Gastroplastia / Redução de Peso / Análise Custo-Benefício Limite: Female / Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Gastroplastia / Redução de Peso / Análise Custo-Benefício Limite: Female / Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido